Acarix USA INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$234Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
183clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2022 $15K
2023 $2,408
2024 $215K
2025 $1,218

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Interventional Cardiology $131K
Clinical Cardiac Electrophysiology $84K
Internal Medicine $15K
Cardiovascular Disease $3,437
Family Medicine $262
Pediatrics (Nurse Practitioner) $166

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Tony Das Dallas, TX Interventional Cardiology $89,096.16
Saumil Oza Jacksonville, FL Clinical Cardiac Electrophysiology $83,400.00
George Chrysant Oklahoma City, OK Interventional Cardiology $40,997.36
Anuj Shah Passaic, NJ Internal Medicine $15,000.00
Marc Bernstein Slidell, LA Cardiovascular Disease $1,200.00
Don Rowe Snellville, GA Cardiovascular Disease $274.90
Gaurav Aggarwala Huntsville, TX Cardiovascular Disease $239.89
Asif Ali Houston, TX Cardiovascular Disease $217.58
Jered Cook Oklahoma City, OK Cardiovascular Disease $190.66
Grace Mitchell Oklahoma City, OK Pediatrics (Nurse Practitioner) $165.68

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.